Circulating tumor cells: utility for predicting response to anti-EGFR therapies?
Mata
Marielena
M
Raponi
Mitch
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D008991:Monitoring, Physiologic; D009369:Neoplasms / Q000188:drug therapy*; D009360:Neoplastic Cells, Circulating; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors